Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Saptak Chem and Business Limited has filed a compliance disclosure confirming there is no deviation in the utilization of funds raised through a preferential issue of convertible warrants. The company issued 40 lakh convertible warrants at Rs. 10.50 each, raising a total consideration of Rs. 4.2 crore. As of now, 25% of the consideration (Rs. 1.05 crore) has been received from allottees. The funds are being used as intended for working capital requirements and providing margin for bank guarantees. The audit committee has reviewed and confirmed no deviation or variation in fund utilization. The filing covers the quarter and year ended March 31, 2026.
This is a routine regulatory filing that provides transparency to shareholders confirming that funds raised through the preferential issue are being deployed as per the original objectives. No adverse news for shareholders, though it indicates the fundraising process is still ongoing with 75% of warrant exercise consideration pending.